Embecta (Nasdaq:EMBC) shares were on the rise before hours today after news of restructuring and mixed second-quarter results.

(NYSE:SENS) shares dipped after hours today on first-quarter results that beat revenue projections on Wall Street.

Insulet (Nasdaq:PODD) shares got a boost after hours today on first-quarter results that came in ahead of the consensus ...

A mission to outer space includes plans to utilize modern diabetes management technology to assess its viability in ...

Phillips Medisize announced that it officially integrated Vectura into its business, expanding its capabilities in inhaled ...

Beta Bionics (Nasdaq:BBNX) shares remained unmoved after hours today on first-quarter results that topped the consensus sales ...

Oura and Stelo alongside the mobile app. [Image courtesy of Dexcom/Oura] Dexcom (NASDAQ:DXCM) announced today that it expanded its partnership with Oura, officially launching an integration with Stelo ...

IDE Group recently unveiled OKO, its new ophthalmic auto-injector for improving drug delivery precision and efficiency.

Medtronic (NYSE:MDT) announced today that it appointed Kate Cronin as the new chief marketing officer for its Diabetes unit.